Sign up to save your podcasts
Or
Share Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
Join us for another insightful episode of The Oncology Brothers as we dive into the Challenging Case Series! In this episode, we were joined by Dr. Eric Singhi, a thoracic medical oncologist from MD Anderson, to discuss the complexities of treating EGFR-positive non-small cell lung cancer (NSCLC).
We explored the latest treatment options, including:
• Osimertinib
• Amivantamab plus Lazertinib (based on the MARIPOSA trial)
• Osimertinib plus chemotherapy (from the FLAURA2 trial)
Listen in as we analyze real-life patient cases, focusing on a 58-year-old gentleman with CNS involvement and a 66-year-old woman experiencing disease progression after initial treatment. Dr. Singhi shared valuable insights on the importance of supportive care, the impact of treatment combinations, and the significance of repeat tissue profiling.
Key topics covered:
• The latest data from the MARIPOSA and FLAURA2 trials
• Strategies for managing side effects and improving patient quality of life
• The role of multidisciplinary teams in treatment planning
• The importance of understanding resistance patterns in treatment decisions
Whether you're a healthcare professional or simply interested in oncology, this episode is packed with essential information and expert perspectives.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from The Oncology Brothers!
#EGFRNSCLC #Mariposa #Amivantamab #Osimertinib #FLAURA2 #OncologyBrothers #LungCancer
View all episodes
By Oncology Brothers
4.8
4040 ratings
Join us for another insightful episode of The Oncology Brothers as we dive into the Challenging Case Series! In this episode, we were joined by Dr. Eric Singhi, a thoracic medical oncologist from MD Anderson, to discuss the complexities of treating EGFR-positive non-small cell lung cancer (NSCLC).
We explored the latest treatment options, including:
• Osimertinib
• Amivantamab plus Lazertinib (based on the MARIPOSA trial)
• Osimertinib plus chemotherapy (from the FLAURA2 trial)
Listen in as we analyze real-life patient cases, focusing on a 58-year-old gentleman with CNS involvement and a 66-year-old woman experiencing disease progression after initial treatment. Dr. Singhi shared valuable insights on the importance of supportive care, the impact of treatment combinations, and the significance of repeat tissue profiling.
Key topics covered:
• The latest data from the MARIPOSA and FLAURA2 trials
• Strategies for managing side effects and improving patient quality of life
• The role of multidisciplinary teams in treatment planning
• The importance of understanding resistance patterns in treatment decisions
Whether you're a healthcare professional or simply interested in oncology, this episode is packed with essential information and expert perspectives.
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from The Oncology Brothers!
#EGFRNSCLC #Mariposa #Amivantamab #Osimertinib #FLAURA2 #OncologyBrothers #LungCancer
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
319 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Research To Practice | Oncology Videos
118 Listeners
ASCO Daily News
58 Listeners
Mayo Clinic Talks
291 Listeners
White Coat Investor Podcast
2,446 Listeners
The Curbsiders Internal Medicine Podcast
3,345 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
The ONS Podcast
198 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
22 Listeners
Becker’s Healthcare Podcast
190 Listeners
Oncology Today with Dr Neil Love
58 Listeners
Two Onc Docs
189 Listeners